Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction
Randomized Double Blind Controlled Trial of the Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this randomized double blind controlled study is to assess the value of robotics for the treatment of complex pelvic floor dysfunction. The main aim is to compare perioperative and functional outcomes to the laparoscopic approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Apr 2011
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 29, 2011
CompletedFirst Posted
Study publicly available on registry
May 3, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedMay 5, 2017
May 1, 2017
9.1 years
April 29, 2011
May 4, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Perioperative outcomes
Including: blood loss, operative time, conversion rate, quality of dissection, pain, complications, hospital stay.
up to 30 days
Secondary Outcomes (1)
Functional results
At 12 months
Study Arms (2)
Robotic
ACTIVE COMPARATORUse of daVinci surgical system (Intuitive Surgical Inc, Sunnyvale, CA) for the treatment of complex pelvic floor dysfunction
Laparoscopy
ACTIVE COMPARATORUse of standard laparoscopy for the treatment of complex pelvic floor dysfunction
Interventions
Use of a minimally invasive approach (robotic or laparoscopy) to perform a rectopexy
Eligibility Criteria
You may qualify if:
- women
- proven pelvic floor dysfunction
- informed consent
You may not qualify if:
- Age \<18 years old
- Patient unable to communicate or to understand the study
- Patient refusing to participate to the study
- contraindication to laparoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nicolas C. Buchslead
Study Sites (1)
University Hospital of Geneva, Department of Surgery
Geneva, 1211, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolas C Buchs, MD
University Hospital, Geneva
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Faculty surgeon
Study Record Dates
First Submitted
April 29, 2011
First Posted
May 3, 2011
Study Start
April 1, 2011
Primary Completion
May 1, 2020
Study Completion
May 1, 2020
Last Updated
May 5, 2017
Record last verified: 2017-05